Form 4 for ETON Eton Pharmaceuticals, Inc.
Accepted 2026-06-17 17:08:00 ET · period of report 2026-06-17 · accession 0001437749-26-021000 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-17 17:08 | 2026-06-17 | ETON | Adams Jennifer McKie | Dir | M - OptEx | $3.78 | +50.0K | 50.0K | New | +$189.0K |
| D | 2026-06-17 17:08 | 2026-06-17 | ETON | Adams Jennifer McKie | Dir | S - Sale+OE | $32.48 | -50.0K | 0 | -100% | -$1.62M |
| D | 2026-06-17 17:08 | 2026-06-17 | ETON | Adams Jennifer McKie | Dir | M - OptEx | $0.00 | -50.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-17 | M | A | 50,000 | $3.78 | 50,000 | D | — | — | |
| 2 | Common | Common Stock | 2026-06-17 | S | D | 50,000 | $32.48 | 0 | D | — | — | (F1) The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. (F3) The shares were sold in multiple trades at prices ranging from $32.10 to $32.71. The price reported above reflects the weighted average sales price. |
| 3 | Derivative | Employee Stock Option | 2026-06-17 | M | D | 50,000 | $0.00 | 0 | D | $3.78 · 2023-02-07 to 2032-02-06 | 50,000 Common Stock | (F2) The shares subject to the option vested on a quarterly basis over 12 months from the date of grant until fully vested on February 7, 2023. |